Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (1011-1020 of 1,281) with videos related to

Pageof 129
Sort By:
Clinical Lung Cancer|January 29, 2011
Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trialPrimo N Lara, Jeff Longmate, Karen Reckamp, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2016
Rare EN1 Variants and Pediatric Bone MassJonathan A Mitchell, Alessandra Chesi, Shana E McCormack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials GroupRaymond Ng, Baktiar Hasan, Nicole Mittmann, et al.
Animals : an Open Access Journal From MDPI|September 5, 2019
At the Intersection of Industry, Academia, and Government: How Do We Facilitate Productive Precision Livestock Farming in Practice?Brett C Ramirez, Hongwei Xin, Patrick G Halbur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trialJean-Yves Douillard, Frances A Shepherd, Vera Hirsh, et al.
Obesity (Silver Spring, Md.)|July 27, 2022
Three-dimensional optical body shape and features improve prediction of metabolic disease risk in a diverse sample of adultsJonathan P Bennett, Yong En Liu, Brandon K Quon, et al.
Human Molecular Genetics|June 5, 2015
A trans-ethnic genome-wide association study identifies gender-specific loci influencing pediatric aBMD and BMC at the distal radiusAlessandra Chesi, Jonathan A Mitchell, Heidi J Kalkwarf, et al.
Phytochemistry|April 14, 2022
Polychlorinated cyclopentenes from a marine derived Periconia sp. (strain G1144)Kristóf B Cank, Robert A Shepherd, Sonja L Knowles, et al.
The European Respiratory Journal|February 16, 2018
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology AssemblyAdrien Costantini, Marta Grynovska, Francesca Lucibello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21Chang-Qi Zhu, Gilda da Cunha Santos, Keyue Ding, et al.
Pageof 129

Showing results (1011-1020 of 1,281) with videos related to

Sort By:
Pageof 129
Clinical Lung Cancer|January 29, 2011
Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trialPrimo N Lara, Jeff Longmate, Karen Reckamp, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2016
Rare EN1 Variants and Pediatric Bone MassJonathan A Mitchell, Alessandra Chesi, Shana E McCormack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials GroupRaymond Ng, Baktiar Hasan, Nicole Mittmann, et al.
Animals : an Open Access Journal From MDPI|September 5, 2019
At the Intersection of Industry, Academia, and Government: How Do We Facilitate Productive Precision Livestock Farming in Practice?Brett C Ramirez, Hongwei Xin, Patrick G Halbur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trialJean-Yves Douillard, Frances A Shepherd, Vera Hirsh, et al.
Obesity (Silver Spring, Md.)|July 27, 2022
Three-dimensional optical body shape and features improve prediction of metabolic disease risk in a diverse sample of adultsJonathan P Bennett, Yong En Liu, Brandon K Quon, et al.
Human Molecular Genetics|June 5, 2015
A trans-ethnic genome-wide association study identifies gender-specific loci influencing pediatric aBMD and BMC at the distal radiusAlessandra Chesi, Jonathan A Mitchell, Heidi J Kalkwarf, et al.
Phytochemistry|April 14, 2022
Polychlorinated cyclopentenes from a marine derived Periconia sp. (strain G1144)Kristóf B Cank, Robert A Shepherd, Sonja L Knowles, et al.
The European Respiratory Journal|February 16, 2018
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology AssemblyAdrien Costantini, Marta Grynovska, Francesca Lucibello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21Chang-Qi Zhu, Gilda da Cunha Santos, Keyue Ding, et al.
Pageof 129